Flebogamma

This page contains recent news articles, when available, and an overview of Flebogamma but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Grifols Announces Capital Investment Plan of Euro 400 Million Over ...  -  Oct 30, 2007
In the USA, the company will invest euro 110 million at its current location in Los Angeles, California to build a new Flebogamma DIF(R) (IVIG) production Earthtimes,

Grifols "sell"  -  Dec 29, 2006
newratings.com...the license for the company to distribute the new generation of Intravenous Immunoglobulin (IVIG) under the name of Flebogamma (R) DIF in the US.

Madrid shares close at session highs, trade thin; Cintra ...  -  Dec 27, 2006
Forbes,...after announcing that it had won a licence from the US Food and Drug Administration to sell its intravenous immunoglobulin drug Flebogamma DIF.

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.